Clinical Trial: A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen(R)) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years

U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07178522) titled 'A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen(R)) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years' on Aug. 21.

Brief Summary: The purpose of this study is to assess the immunogenicity and safety of EV71 vaccine (Envacgen(R)) in Children Aged 6 to <10 Years compared to Children Aged 2 to <6 Years.

Study Start Date: June 25

Study Type: INTERVENTIONAL

Condition: Enterovirus 71 Inactivated Vaccine

Intervention: BIOLOGICAL: Envacgen(R)

Subjects are to receive a 0.5 mL IM injection of Envacgen(R). Study drug is administered on Day 1 and Day 57 of the study.

Recruitment Stat...